Exogenous BMP4 augmented glycogen accumulation and upregulated the expression of glycogenesis-related and glycogenolysis-related genes in HCC cells, both of which were effectively blunted by SLC2A1inhibitor BAY-876. This evidence concerns the gene BMP4 and hepatocellular carcinoma.